DUBLIN and BARCELONA, Two real-world analyses featuring the Medtronic plc (NYSE: MDT) AdaptivCRT(TM) algorithm reinforce that its use is linked to a reduction in atrial fibrillation (AF) episodes, as ...

Study Supplements Earlier Data Showing Reduction in Hospital Readmissions for Heart Failure Patients with AdaptivCRT Technology MINNEAPOLIS, USA and NICE, FRANCE - New data from the Medtronic, Inc.

Please provide your email address to receive an email when new articles are posted on . Among the features of the new European Society of Cardiology guideline on pacing and cardiac resynchronization ...

Allure Quadra elevates the standard for Cardiac Resynchronization Therapy Pacemakers Allure Quadra(TM) CRT-P (Photo: St. Jude Medical, Inc.) "Adding quadripolar technology to the CRT-P platform moves ...

Please provide your email address to receive an email when new articles are posted on . The use of cardiac resynchronization therapy devices and implantable cardioverter defibrillators was associated ...

In a tight vote Tuesday, a U.S. Food and Drug Administration Circulatory Systems Device Advisory Panel recommended Medtronic‘s (MDT) CRT devices are beneficial for biventricular pacing when treating ...

Medical device major Medtronic plcMDT recently presented an economic analysis of five-year data on cardiac resynchronization therapy (CRT) devices within its Cardiac Rhythm & Heart Failure (CRHF) ...

November 14, 2010 (Chicago, Illinois) — Results of the first trial to show that cardiac resynchronization therapy (CRT) provides a survival benefit beyond that of implantable cardioverter ...

Medtronic has begun shipping its Consulta and Syncra cardiac resynchronization therapy-pacemaker (CRT-P) systems now that the FDA given its blessing for the products. Consulta is the first CRT-P that ...

New York, NY and Oxford, UK - Whether by region in the US or by country in Europe, there is wide variation in the likelihood that an eligible patient with heart failure will receive a biventricular ...